CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report

BACKGROUND: Adults with relapsed acute lymphoblastic leukemia (ALL) have a poor prognosis, especially in patients who relapsed within 6 months of complete remission 1 (CR1). Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the treatment of choice. However, this can only be considere...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Shupeng, Niu, Zhiyun, Xing, Lina, Wang, Ying, Li, Hang, Kuang, Na, Luo, Jianmin, Zhang, Xuejun, Wang, Fuxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245806/
https://www.ncbi.nlm.nih.gov/pubmed/30458755
http://dx.doi.org/10.1186/s12885-018-5037-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245806/
https://www.ncbi.nlm.nih.gov/pubmed/30458755
http://dx.doi.org/10.1186/s12885-018-5037-7

Ejemplares similares